Novel insights into regulation of plasma triglyceride levels

Slides:



Advertisements
Similar presentations
Long-term Complications of Type 2 Diabetes
Advertisements

ADIPONECTIN Its emerging role in Atherosclerosis, Metabolic Syndrome and Insulin Resistance RT ERASMUS Chemical Pathology, Tygerberg Hospital, NHLS &University.
Biology of Lipid Metabolism Laboratory. People Lab head Matthew Watt Research Assistant Maria Matzaris.
DO YOU HAVE THE METABOLIC SYNDROME? You're never too young to have it Jacqueline A. Eberstein, R.N.
Lipoprotein Structure, Function, and Metabolism
Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference Circulation. 2004;109:
LIPOPROTEIN METABOLISM
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Adiposity in CVD. Role of adipose tissue in atherogenesis Adapted from de Luca C, Olefsky JM. Nat Med. 2006;12:41-2. Lau DCW et al. Am J Physiol Heart.
Source: International Chair on Cardiometabolic Risk Fatty Acid Metabolism in Humans Michael Jensen, MD Division of Endocrinology.
Role of PXR Signaling in Mediating the Cardioprotective Effects of  -3 Fatty Acids Saraswathi Viswanathan, Ph.D. Assistant Professor Department of Internal.
Diabetic Dyslipidemia and Atherosclerosis Henry Ginsberg, MD
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Endocrine Block | 1 Lecture | Dr. Usman Ghani
Cholesterol is among the lipids (fats) in the bloodstream. Source: Supplied from diet or synthesized by liver. Importance: 1.Form cell membranes and.
By Hussam A.S. Murad and Khaled A. Mahmoud Department of Pharmacology and Therapeutics Faculty of Medicine, Ain Shams University By Hussam A.S. Murad.
Physiological Role and Molecular Mechanism of Adiponectin Yumi Ando Pomona College Advanced Biochemistry.
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
cardio protection: Focus on
STEVIA SYMPOSIUM LEUVEN July 2009 EFFECT OF STEVIOSIDE ON ATHEROSCLEROSIS IN A MOUSE MODEL OF THE METABOLIC SYNDROME Paul Holvoet Atherosclerosis and Metabolism.
The Road To Metabolic syndrome
Obesity Dr. Sumbul Fatma. Obesity A disorder of body weight regulatory systems Causes accumulation of excess body fat >20% of normal body weight Obesity.
Diabetes Mellitus Type 2
LAB (6): LIPIDS PROFILE KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2013.
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
HANDBOOK OF DYSLIPIDEMIA AND ATHEROSCLEROSIS Part One Professor Jean-Charles Fruchart Department of Atherosclerosis (Inserm UR545) Pasteur Institute of.
Metabolic Syndrome Endocrine Block 1 Lecture Dr. Usman Ghani.
Lab (6): Lipids profile KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2012 T.A Nouf Alshareef
Copyright © 2016 McGraw-Hill Education. All rights reserved.
PPAR δ : a dragger in the heart of the metabolic syndrome J.Clin.Invest.116:590~597(2006) R3 Song Se-bin Grant D. Barish, Vihang A.Narkar, and Ronald M.Evans.
Cardiovascular Disease: Risk Factors and Risk Assessment
Lipids profile.
Lipoproteins and Atheroscloresis
Lipoproteins and Atheroscloresis
Endocrine Block 1 Lecture Dr. Usman Ghani
OBESITY.
Chapter 7 Metabolic syndrome
Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS
TOTAL CHOLESTEROL.
By Dr. Sumbul Fatma Clinical Chemistry Unit Department of Pathology
Obesity Dr. Sumbul Fatma.
Plasma Lipid Transport Role of HDL
Endocrine Block 1 Lecture Dr. Usman Ghani
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
A novel approach to target fasting and post-prandial triglycerides
by Kiran Musunuru, and Sekar Kathiresan
Intermyocellular fat depot
“Sick Fat,” Metabolic Disease, and Atherosclerosis
Genes and environment in type 2 diabetes and atherosclerosis
“Sick Fat,” Metabolic Disease, and Atherosclerosis
המשותף לכל סוגי הסוכרת היפרגליקמיה כרונית.
Back to the Basics of Dyslipidemia
Vascular biology of metabolic syndrome
In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia
Advanced Nutrition Diet and Cardiovascular Disease 1
CLA-1/SR-BI protein may promote cholesterol removal from peripheral cells Figure 84 The CLA-1 receptor is the human homolog of the SR-I receptor in mice.
THE ENDOCANNABINOID SYSTEM AND CARDIOMETABOLIC RISK
Ludger Scheja, Joerg Heeren  Journal of Hepatology 
Interaction of hypercholesterolemia and inflammation in atherogenesis
Dual Role of Circulating Angiopoietin-Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome  Nosratola D.
Lipoproteins.
Selective versus Total Insulin Resistance: A Pathogenic Paradox
“De-liver-ance” From CB1: A Way to Counteract Insulin Resistance?
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
A whole body model for both glucose and fatty acid metabolism
In and Out: Adipose Tissue Lipid Turnover in Obesity and Dyslipidemia
Section overview: Cardiometabolic risk reduction
CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome
Lipoprotein Metabolism
Lipoproteins   Macromolecular complexes in the blood that transport lipids Apolipoproteins   Proteins on the surface of lipoproteins; they play critical.
Presentation transcript:

Novel insights into regulation of plasma triglyceride levels Sander Kersten, Nutrition Metabolism and Genomics group, Wageningen University, the Netherlands

High plasma triglycerides as part of elevated CVD risk profile Atherogenic dyslipidemia  Triglycerides  HDL-cholesterol  Cholesterol/HDL-cholesterol ratio «Normal» LDL-cholesterol but  apo B Small, dense LDL and HDL Postprandial hyperlipidemia Inflammation Insulin resistance Hyperinsulinemia Hyperglycemia Type 2 diabetes Lipid core Cluster of metabolic athero-thrombotic and pro-inflammatory disturbances resulting from visceral obesity, contributing not only to the progression of coronary atherosclerosis, but also increasing the risk of an acute coronary syndrome. KW: metabolic syndrome, risk factors, obesity, diabetes Thin fibrous cap Thrombotic state  PAI-1  Fibrinogen CORONARY ATHEROSCLEROSIS UNSTABLE PLAQUE Inflammatory state  CRP  Cytokines Increased risk of acute coronary syndrome Abdominal obesity Metabolic risk factors

Efficacy of fibrates in CVD risk reduction

Traditional view of triglyceride hydrolysis

Phenotype of Gpihbp1 -/- mice Beigneux et al. Cell Metabolism 2007

LPL does not reach the endothelial surface in Gpihbp1 -/- mice Davies et al. Cell Metabolism 2010

Gpihbp1 carries LPL from myocyte/ adipocyte to endothelial surface

Mutations in GPIHBP1 gene lead to severe hypertriglyceridemia COOH G Adapted from Young, JLR 2011

Family of Angiopoietin-like proteins regulate LPL activity Regulation of plasma TG ANGPTL8 Adapted from Zhang, BBRC 2013

Liver derived Angptl3 and Angptl8 inhibit peripheral LPL activity

Hypertriglyceridemic effect of Angptl3 may depend on Angptl8 Plasma TAG level did not change in mice expressing ANGPTL3 alone, whereas coexpression with ANGPTL8 resulted in hypertriglyceridemia, despite a reduction in circulating ANGPTL3. ANGPTL8 coimmunoprecipitated with the N-terminal domain of ANGPTL3 in plasma of these mice. In cultured hepatocytes, ANGPTL8 expression increased the appearance of N-terminal ANGPTL3 in the medium, suggesting ANGPTL8 may activate ANGPTL3. Consistent with this scenario, expression of ANGPTL8 in Angptl3(-/-) mice failed to promote hypertriglyceridemia Adapted from Quagliarini, PNAS 2013

Mutations in ANGPTL3 gene lead to familial combined hypolipidemia Low plasma levels of total cholesterol, LDL-C, HDL-C and triglycerides or combinations thereof

Angptl4 inhibits LPL and plasma TG clearance

Potent hypertriglyceridemic effect of Angptl4 overexpression Angptl4-Tg

E40K mutation completely disables LPL inhibition by Angptl4

Support from Genome- Wide Association Studies 30 GWAS loci (n=19840) affecting blood lipids at p<5x10-8 VLDLR GPIHBP1 Kathiresan et al. Nature Genetics 2009 PPARG

Decrease in LPL activity during fasting is abolished in Angptl4-/- mice Wildtype Angptl4-/- Kroupa et al. BMC Physiol. 2012

Angptl4 governs adipose LPL activity during fasting and feeding Diminished fatty acid uptake into adipose tissue Enhanced fatty acid uptake into adipose tissue

Angptl4 as proposed mediator between gut microbiota and fat storage Based on Backhed et al. PNAS 2004

ANGPTL4 is the most significantly upregulated gene in the non-exercising leg

ANGPTL4 is specifically increased in the non-exercising leg

ANGPTL4 is slightly more abundant in slow twitch fibers

Acute exercise but not training induces plasma ANGPTL4 levels One leg Two legs

Angptl4 is induced by a circulating factor * * *

Angptl4 is highly induced by fatty acids in cultured myotubes Oleic acid treatment in C2C12 cells

Angptl4 upregulation reduces LPL activity in vitro

Suppression ANGPTL4 in exercising muscle may be mediated by AMPK

Exercise studies in Angptl4-transgenic and wildtype mice Angptl4 overexpression reduces plasma TG-derived fatty acid uptake into muscle during exercise

Angptl4 directs lipid fuels from non-exercising to exercising muscle

Conclusions GPIHBP1 and Angiopoietin-like proteins are important players in regulation of plasma lipoprotein levels Angptl4 is a crucial regulator of LPL and consequent fat uptake in skeletal muscle and white adipose tissue

Wageningen University Sheril Alex Milene Catoire Frits Mattijssen Nicolas Paraskevupolos Anastasia Georgiadi Karin Mudde Rinke Stienstra Michael Müller Leiden University Patrick Rensen Jimmy Berbee Yanan Wang Cornell University, USA Ling Qi Umea University, Sweden Gunilla Olivercrona Maastricht University Patrick Schrauwen Matthijs Hesselink Utrecht University Eric Kalkhoven Nanyang Technological University Nguan Soon Tan